Background pattern
Medicine image

Nuvaring 0,120 mg/0,015 mg cada 24 horas, sistema de liberacion vaginal

About the medication

Introduction

Label: information for the user

NuvaRing 0.120 mg/0.015 mg every 24 hours, vaginal delivery system

etonogestrel/ethinyl estradiol

Important things you should know about combined hormonal contraceptives (CHCs):

  • They are one of the most reliable reversible contraceptive methods if used correctly.
  • They slightly increase the risk of suffering a blood clot in the veins and arteries, especially in the first year or when restarting use of a combined hormonal contraceptive after a pause of 4 weeks or more.
  • Be alert and consult your doctor if you think you may have symptoms of a blood clot (see section 2 “Blood clots”).

Read this label carefully before starting to use NuvaRing, because it contains important information for you.

  • Keep this label, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed only to you, and you should not give it to others, as it may harm them.
  • If you experience adverse effects, consult your doctor or pharmacist, even if they are not listed in this label. See section 4.

1.What is NuvaRing and how it is used

2.What you need to know before starting to use NuvaRing

3.How to use NuvaRing

4.Possible adverse effects

5.Storage of NuvaRing and the NuvaRing Applicator

6.Contents of the package and additional information

1. What is NuvaRing and what is it used for

NuvaRing is a vaginal contraceptive ring used to prevent pregnancy. Each ring contains a small amount of two female sex hormones, etonogestrel and ethinylestradiol. The ring releases these hormones slowly into the bloodstream. Given the small amount of hormones released, NuvaRing is a low-dose hormonal contraceptive. As NuvaRing releases two different types of hormones, it is a combined hormonal contraceptive.

NuvaRing acts like the combined oral contraceptive pill (the “Pill”), but instead of taking a pill every day, the ring is used for 3 consecutive weeks. NuvaRing releases two female sex hormones that prevent the ovaries from releasing an egg. If no egg is released, you cannot become pregnant.

2. What you need to know before starting to use NuvaRing

General Considerations

Before starting to use NuvaRing, read the information about blood clots in section 2. It is particularly important that you read the symptoms of a blood clot (see section 2 “Blood Clots”).

This leaflet describes various situations in which you should stop using NuvaRing, or in which NuvaRing may be less reliable. In these situations, you should not have sexual intercourse, or you should take additional non-hormonal contraceptive measures, such as a male condom.Do not use the rhythm or basal body temperature method. These methods may not be reliable because NuvaRing alters the monthly body temperature changes and cervical mucus.Do not use NuvaRing with the rhythm or basal body temperature method.

NuvaRing, like other hormonal contraceptives, does not protect against HIV (AIDS) or any other sexually transmitted disease.

2.1 When not to use NuvaRing

You should not use NuvaRing if you have any of the conditions listed below. Inform your doctor if you have any of the conditions listed below. Your doctor will discuss with you what other form of contraception would be more suitable.

  • If you have (or have ever had) a blood clot in a vein in your leg (deep vein thrombosis, DVT), in your lungs (pulmonary embolism, PE), or in other organs.
  • If you know that you have a disorder that affects blood clotting: for example, protein C deficiency, protein S deficiency, antithrombin III deficiency, factor V Leiden, or antiphospholipid antibodies.
  • If you need surgery or if you spend a lot of time without getting up (see section “Blood Clots”).
  • If you have ever had a heart attack or a stroke.
  • If you have (or have ever had) angina pectoris (a condition that causes severe chest pain and may be the first sign of a heart attack) or a transient ischemic attack (TIA, symptoms of a stroke).
  • If you have any of the following diseases that may increase your risk of forming a blood clot in your arteries:

− Severe diabetes with vascular damage.

  • Very high blood pressure.
  • Very high levels of fat in your blood (cholesterol or triglycerides).
  • A condition called hyperhomocysteinemia.
    • If you have (or have ever had) a type of migraine called “migraine with aura”.
    • If you have or have had pancreatitis (inflammation of the pancreas) associated with high levels of fat in your blood.
    • If you have or have had a serious liver disease and your liver is not functioning normally.
    • If you have or have had a benign or malignant tumor in the liver.
    • If you have, have had, or may have breast cancer or cancer of the reproductive organs.
    • If you have unexplained vaginal bleeding.
    • If you are allergic to ethinylestradiol or etonogestrel, or to any of the other components of this medication (including those listed in section 6).

If any of these circumstances occur for the first time while using NuvaRing, remove the ring immediately and consult your doctor. Meanwhile, use non-hormonal contraceptive measures.

Do not use NuvaRing if you have hepatitis C and are taking medications that contain ombitasvir/paritaprevir/ritonavir and dasabuvir or glecaprevir/pibrentasvir (see also section 2.4 “Other Medications and NuvaRing”).

2.2 Warnings and Precautions

When to consult your doctor?

Seek urgent medical attention

  • If you notice possible signs of a blood clot that may mean you are suffering from a blood clot in your leg (deep vein thrombosis), a blood clot in your lung (pulmonary embolism), a heart attack, or a stroke (see section “Blood Clots” below).

For a description of the symptoms of these serious adverse effects, see “How to Recognize a Blood Clot”.

Inform your doctor if you suffer from any of the following conditions.

Inform your doctor if the condition develops or worsens while you are using NuvaRing.

  • If any of your close relatives have had or have cancer of the breast.
  • If you suffer from epilepsy (see section 2.4 “Other Medications and NuvaRing”).
  • If you have a liver disease (for example, jaundice) or a gallbladder disease (for example, gallstones).
  • If you have inflammatory bowel disease (Crohn's disease or ulcerative colitis).
  • If you have systemic lupus erythematosus (SLE, a disease that affects your natural defense system).
  • If you have hemolytic uremic syndrome (HUS, a disorder of blood clotting that causes kidney failure).
  • If you have sickle cell anemia (a hereditary disorder of red blood cells).
  • If you have high levels of fat in your blood (hypertriglyceridemia) or a known family history of this condition. Hypertriglyceridemia has been associated with an increased risk of pancreatitis (inflammation of the pancreas).
  • If you need surgery or spend a lot of time without getting up (see section 2 “Blood Clots”).
  • If you are at greater risk of blood clots after childbirth. Ask your doctor when you can start using NuvaRing again after childbirth.
  • If you have superficial thrombophlebitis (inflammation of the veins under the skin).
  • If you have varicose veins.
  • If you have a disease that appeared for the first time or worsened during pregnancy or previous use of sex hormones (for example, hearing loss, porphyria [a blood disorder], herpes of pregnancy [skin rash with blisters during pregnancy], or Sydenham's chorea [a nervous disorder with involuntary movements].
  • If you experience symptoms of angioedema, such as swelling of the face, tongue, and/or throat, and/or difficulty swallowing, or urticaria possibly with difficulty breathing, contact your doctor immediately. Medications containing estrogens can cause or worsen the symptoms of hereditary and acquired angioedema.
  • If you have or have had melasma (brownish-yellow patches on the skin, called “pregnancy patches,” particularly on the face); if this is the case, avoid excessive exposure to the sun or ultraviolet rays.
  • If you have disorders that make it difficult to use NuvaRing, for example, if you have constipation, uterine prolapse (uterine or cervical descent), or experience pain during sexual intercourse.
  • If you have a sudden urge to urinate, frequent urination, burning, and/or painful urination, and cannot locate the ring in your vagina. These symptoms may indicate that the ring has been accidentally placed in your urinary bladder.

BLOOD CLOTS

The use of a combined hormonal contraceptive like NuvaRing increases your risk of suffering a blood clot compared to not using it. In rare cases, a blood clot can block blood vessels and cause serious problems.

Blood clots can form:

  • In veins (called “deep vein thrombosis,” “venous thromboembolism,” or VTE).
  • In arteries (called “arterial thrombosis,” “arterial thromboembolism,” or ATE).

The recovery of blood clots is not always complete. In rare cases, there may be long-lasting or even fatal effects.

It is essential to remember that the overall risk of a blood clot that can cause harm due to NuvaRing is small.

HOW TO RECOGNIZE A BLOOD CLOT

Seek urgent medical attentionif you notice any of the following signs or symptoms.

Do you experience any of these signs?

What could you be suffering from?

  • Swelling of a leg or foot or along a vein in your leg or foot, especially when accompanied by:
  • Pain or tenderness in your leg, which may only be noticeable when you stand up or walk.
  • Increased temperature in the affected leg.
  • Change in skin color of the leg, for example, if it becomes pale, red, or blue.

Deep vein thrombosis

  • Sudden shortness of breath without a known cause or rapid breathing.
  • Sudden coughing without a clear cause, which may bring up blood.
  • Severe chest pain that may worsen with deep breathing.
  • Intense dizziness or fainting.
  • Irregular or rapid heartbeat.
  • Severe stomach pain.

If you are unsure, consult a doctor, as some of these symptoms, such as coughing or shortness of breath, can be confused with a less severe condition like a common cold.

Pulmonary embolism

Symptoms that occur more frequently in one eye:

  • Immediate loss of vision. Or
  • Blurred vision without pain, which may progress to loss of vision.

Retinal vein thrombosis (blood clot in the eye).

  • Chest pain, discomfort, pressure, or heaviness.
  • Feeling of fullness or oppression in the chest, arm, or under the sternum.
  • Feeling of fullness, indigestion, or choking.
  • Discomfort in the upper body that radiates to the back, jaw, throat, arm, and stomach.
  • Sweating, nausea, vomiting, or dizziness.
  • Extreme weakness, anxiety, or shortness of breath.
  • Irregular or rapid heartbeat.

Heart attack

  • Sudden weakness or numbness on one side of the face, arm, or leg.
  • Confusion, difficulty speaking, or understanding.
  • Difficulty seeing in one eye or both eyes.
  • Difficulty walking, dizziness, loss of balance, or coordination.
  • Sudden severe headache, intense or prolonged.
  • Loss of consciousness or fainting, with or without convulsions.

Sometimes, the symptoms of a stroke may be brief, with almost immediate and complete recovery, but you should still seek urgent medical attention because you may be at risk of another stroke.

Stroke

  • Swelling and slight bluish discoloration of an extremity.
  • Severe stomach pain (abdominal pain).

Blood clots that block other blood vessels.

BLOOD CLOTS IN A VEIN

What can happen if a blood clot forms in a vein?

  • The use of combined hormonal contraceptives has been associated with an increased risk of blood clots in veins (venous thrombosis). However, these adverse effects are rare. They occur more frequently in the first year of use of a combined hormonal contraceptive.
  • If a blood clot forms in a vein in your leg or foot, it may cause deep vein thrombosis (DVT).
  • If a blood clot breaks loose from your leg and lodges in your lung, it may cause a pulmonary embolism.
  • In rare cases, a blood clot can form in a vein in another organ, such as your eye (retinal vein thrombosis).

When is the risk of a blood clot in a vein higher?

The risk of a blood clot in a vein is higher during the first year you use a combined hormonal contraceptive for the first time. The risk may be higher if you restart using a combined hormonal contraceptive (the same medication or a different one) after a break of 4 weeks or more.

After the first year, the risk decreases, but it is always slightly higher than if you were not using a combined hormonal contraceptive.

When you stop using NuvaRing, your risk of a blood clot returns to normal in a few weeks.

What is the risk of a blood clot?

The risk depends on your natural risk of VTE and the type of combined hormonal contraceptive you are using.

The overall risk of a blood clot in your leg or lung (DVT or PE) with NuvaRing is small.

  • Of every 10,000 women who do not use a combined hormonal contraceptive and are not pregnant, 2 will develop a blood clot in a year.
  • Of every 10,000 women who use a combined hormonal contraceptive containing levonorgestrel, noretisterone, or norgestimato, 5-7 will develop a blood clot in a year.
  • Of every 10,000 women who use a combined hormonal contraceptive containing norelgestromin or etonogestrel, such as NuvaRing, 6-12 will develop a blood clot in a year.
  • The risk of a blood clot will depend on your personal history (see “Factors that increase your risk of a blood clot” below).

Factors that increase your risk of a blood clot in a vein

The risk of a blood clot is higher:

  • If you are overweight (body mass index (BMI) greater than 30 kg/m2).
  • If any of your close relatives have had a blood clot in their leg, lung, or other organ at a young age (i.e., before about 50 years old). In this case, you may have an inherited disorder of blood clotting.
  • If you need surgery or spend a lot of time without getting up due to an injury or illness, or if you have your leg immobilized. You may need to stop using NuvaRing for several weeks before surgery or while you have limited mobility. If you need to stop using NuvaRing, ask your doctor when you can start using it again.
  • As you get older (especially over about 35 years old).
  • If you have given birth recently.

The risk of a blood clot increases the more conditions you have.

Long flights (over 4 hours) may temporarily increase your risk of a blood clot, especially if you have any of the other risk factors listed.

It is essential to inform your doctor if you have any of the conditions listed above, even if you are unsure. Your doctor may decide that you should stop using NuvaRing.

If any of the conditions listed above change while you are using NuvaRing, for example, a close relative experiences a blood clot without a known cause or you gain a lot of weight, inform your doctor.

BLOOD CLOTS IN AN ARTERY

What can happen if a blood clot forms in an artery?

Like a blood clot in a vein, a blood clot in an artery can cause serious problems. For example, it can cause a heart attack or a stroke.

Factors that increase your risk of a blood clot in an artery

It is essential to note that the risk of a heart attack or stroke due to NuvaRing is very small, but it may increase:

  • With age (over about 35 years old).
  • If you smoke.
  • If you are overweight.
  • If you have high blood pressure.
  • If any of your close relatives have had a heart attack or stroke at a young age (less than about 50 years old). In this case, you may also be at higher risk of a heart attack or stroke.
  • If you or any of your close relatives have high levels of fat in your blood (cholesterol or triglycerides).
  • If you have migraines, especially migraines with aura.
  • If you have a heart problem (valve disorder, abnormal heart rhythm called atrial fibrillation).
  • If you have diabetes.

If you have one or more of these conditions or if any of them are particularly severe, your risk of a blood clot may be increased even further.

If any of the conditions listed above change while you are using NuvaRing, for example, you start smoking, a close relative experiences a blood clot without a known cause, or you gain a lot of weight, inform your doctor.

CANCER

The following information has been obtained from studies with combined oral contraceptives and may be applicable to NuvaRing. There is no information available on the vaginal administration of hormone contraceptives (such as NuvaRing).

Cases of breast cancer have been observed with a slightly higher frequency in women using oral contraceptives, but it is unknown whether this is due to treatment. For example, it may be that more tumors are found in women using oral contraceptives because they attend medical check-ups more frequently. This increased frequency decreases gradually after stopping treatment.

It is essential to examine your breasts regularly and inform your doctor if you notice any lump. Inform your doctor if any of your close relatives have had or have breast cancer (see section 2.2 “Warnings and Precautions”).

Rare cases of benign liver tumors and, even more rarely, malignant liver tumors have been reported in women using oral contraceptives. Contact your doctor if you have severe and unusual abdominal pain.

Combined oral contraceptives have been associated with a lower incidence of endometrial cancer (the lining of the uterus) or ovarian cancer. This may also be the case with NuvaRing, but it has not been confirmed.

PSYCHIATRIC DISORDERS

Some women who use hormonal contraceptives like NuvaRing have reported depression or a depressed mood. Depression can be severe and sometimes may induce suicidal thoughts. If you experience mood changes and depressive symptoms, contact your doctor for additional medical advice as soon as possible.

  1. Children and Adolescents

The safety and efficacy of NuvaRing have not been established in adolescents under 18 years old.

  1. Other Medications and NuvaRing

Always inform your doctor about any medications or herbal remedies you are taking. Also, inform any doctor, dentist, or pharmacist (or pharmacist) who prescribes another medication that you are using NuvaRing. They can inform you if you need to take additional contraceptive measures (for example, use a male condom) and, if necessary, for how long, or if you need to modify the use of the other medication.

Some medications

  • may affect the levels of NuvaRing in your blood;
  • may make it less effective in preventing pregnancy;
  • may cause unexpected bleeding.

These include medications used to treat:

  • epilepsy (for example, primidone, phenytoin, barbiturates, carbamazepine, oxcarbazepine, topiramate, felbamate);
  • tuberculosis (for example, rifampicin);
  • HIV infection (for example, ritonavir, nelfinavir, nevirapina, efavirenz);
  • hepatitis C infection (for example, boceprevir, telaprevir);
  • other infectious diseases (for example, griseofulvin);
  • high blood pressure in the blood vessels of the lungs (bosentan);
  • mood disorders (the herbal remedy St. John's Wort).

If you are taking medications or herbal remedies that may make NuvaRing less effective, you should also use a barrier contraceptive method (for example, a male condom). Since the effect of another medication on NuvaRing may last for up to 28 days after stopping the medication, you will need to use an additional barrier contraceptive method during that time. Note: Do not use NuvaRing with a diaphragm, cervical cap, or female condom.

NuvaRing mayinfluence the effectof other medications, for example:

-medications containing ciclosporin

-the antiepileptic lamotrigine (this could lead to an increase in seizure frequency).

Do not useNuvaRingif you have Hepatitis C and are taking medications that contain

ombitasvir/paritaprevir/ritonavir and dasabuviror glecaprevir/pibrentasvir, increased liver enzyme levels (ALT) may occur.

Your doctor will prescribe another type of contraceptive before starting treatment with these

medications.

NuvaRing can be used again approximately 2 weeks after the end of this treatment. See section2.1When not to use NuvaRing.

Consult your doctor or pharmacist before taking any medication.

You can use tampons while using NuvaRing. First, insert NuvaRing, and then the tampon. Be especially careful when removing the tampon to avoid accidentally expelling the ring. If the ring is expelled, simply wash it with cold or lukewarm water and reinsert it immediately.

The ringcan be openedwhenyou are alsousing a vaginal product such as a lubricant or a treatment for an infection (see section 3.4“What to do if… The ring is open).The use of spermicides or vaginal antifungal products does not reduce the effectiveness of NuvaRing as a contraceptive.

Laboratory Tests

If you have blood or urine tests, inform your doctor that you are using NuvaRing, as it may affect the results of some tests.

  1. Pregnancy and Breastfeeding

Women who are pregnant or suspect they may be pregnant should not use NuvaRing. If you become pregnant while using NuvaRing, remove the ring and consult your doctor.

If you want to stop using NuvaRing because you want to become pregnant, see section 3.5 “Stopping NuvaRing”.

Generally, it is not recommended to use NuvaRing while breastfeeding. If you want to use NuvaRing while breastfeeding, consult your doctor.

  1. Driving and Operating Machinery

NuvaRing is unlikely to affect your ability to drive or operate machinery.

3. How to use NuvaRing

You can put and take NuvaRing yourself. Your doctor will tell you when to start using it for the first time. The vaginal ring must be inserted on the correct day of your menstrual cycle (see section 3.3 “When to start with the first ring”) and remain in the vagina for 3 consecutive weeks. Check regularly that NuvaRing is in your vagina (for example, before and after sexual intercourse) to ensure that you are protected against pregnancy. After the third week, remove NuvaRing and leave a week of rest. You will usually have your menstrual period or bleeding during this pause without a ring.

While using NuvaRing, you should not use some barrier female contraceptives, such as the vaginal diaphragm, cervical cap, or female condom. These barrier contraceptives should not be used as a backup method of birth control since NuvaRing may interfere with the correct placement and position of the diaphragm, cervical cap, or female condom. However, you can use a male condom as an additional barrier contraceptive method.

3.1 How to put on and take off NuvaRing

  1. Before putting on the ring, check that it is not expired (see section 5 “Storage of NuvaRing and the NuvaRing Applicator”).
  2. Wash your hands before putting on or taking off the ring.
  3. Choose a comfortable position for you to insert it, for example, standing with one leg raised, squatting, or lying down.
  4. Remove NuvaRing from its package.
  5. Hold the ring between your index and middle fingers, press the opposite sides, and insert the ring into the vagina (see figures 1-4).Alternatively, you can use the NuvaRing Applicator to help you insert the ring (see the usage instructions below).When NuvaRing is in place, you should not feel anything. If you feel uncomfortable, change the position of NuvaRing (for example, push the ring a little further into the vagina) until you feel comfortable.The exact position of the ring inside the vagina is not important.
  6. After 3 weeks, remove NuvaRing from the vagina. You can do this by hooking the ring with your index finger or holding it with your fingers and pulling it out (see figure 5). If you cannot remove the ring despite having located it, contact your doctor.
  7. Dispose of the used ring in the household trash, preferably in its package. Do not flush NuvaRing down the toilet.

Insertion of NuvaRing only with your fingers:

Figure 1

Remove NuvaRing from its package

Figure 2

Press the ring

Figure 3

Choose a comfortable position to put on the ring

Figure 4AFigure 4BFigure 4C

Put the ring in the vagina with one hand (Figure 4A), if necessary, separate the vaginal lips with the other. Push the ring into the vagina until you feel comfortable (Figure 4B). Leave the ring in the vagina for 3 weeks (Figure 4C).

Figure 5

NuvaRing can be removed by hooking the ring with your index finger or holding it with your index and middle fingers and pulling it out.

Important information about the NuvaRing Applicator:

  1. Optional use to help insert NuvaRing.
  2. DO NOT reuse the applicator; it is designed for single use only.
  3. DO NOT share the applicator with others.
  4. If the applicator falls accidentally, wash the applicator with cold or lukewarm water (DO NOT use hot water).
  5. Dispose of the applicator in the trash immediately after use.
  6. Do not flush the applicator down the toilet.

Insertion of NuvaRing with the applicator:

1: Preparation

Wash your hands before opening the package. Always open immediately before use. DO NOT use if the contents or package are visibly damaged.

The applicator is designed to be used ONLY with the NuvaRing ring, not with other products.

Examine the applicator image to familiarize yourself with its parts.

A. Plunger
B. Holding area
C. Applicator tube
D. Tube opening

E. NuvaRing ring

2: Loading and placement

Pull the plunger back gently until it stops.

Press the opposite sides of the ring and insert the ring into the tube opening of the applicator.

Push the ring gently into the tube. The ring end should protrude slightly from the tube opening of the applicator.

Choose a comfortable position to insert the ring, for example, lying down, squatting, or standing with one leg raised.

3: Insertion and removal

Place your thumb and index finger on the holding area.

Insert the applicator tube gently into the vagina until your fingers (the holding area of the applicator) come into contact with your body.
Next, use your index finger to push the plunger completely into the tube.

Some women have reported a brief sensation of mild pinching when using the applicator.

The ring is pushed out of the applicator. Remove the applicator gently.

Make sure the ring is no longer inside the applicator. Dispose of the used applicator in the trash. DO NOT flush the applicator down the toilet. DO NOT reuse the applicator.

3.2 Three weeks in, one week out

  1. The vaginal ring must remain in the vagina from the day you put it in for 3 consecutive weeks, uninterrupted.
  2. After 3 weeks, remove the ring on the same day of the week and at the same time as you put it in. For example, if you put it in on a Wednesday around 10:00 PM, remove it 3 weeks later, on a Wednesday, around 10:00 PM.
  3. Once you have removed the ring, do not use it for a week. During this week, you should experience vaginal bleeding. Normally, it starts 2-3 days after removing the NuvaRing.
  4. Put a new ring exactly 1 week after removing the previous one (again, on the same day of the week and around the same time), even if you have not stopped bleeding yet.
  5. If you put on a new ring more than 3 hours late, the contraceptive effectiveness may be reduced. Follow the instructions in section 3.4 “What to do if you forget to put on a new ring after the pause without a ring.”

If you use NuvaRing as described above, your bleeding will occur approximately on the same days each month.

3.3 When to start with the first ring

  • If you have not usedhormonal contraceptionin the previous month

Put on NuvaRing on the first day of your natural cycle (i.e., the first day of your menstruation). NuvaRing starts working immediately. You do not need to take any other contraceptive measures.

You can also start with NuvaRing between days 2 and 5 of your cycle, but if you have sexual intercourse during the first 7 days of using NuvaRing, make sure to use an additional contraceptive method (such as a male condom). You should only follow this recommendation when using NuvaRing for the first time.

  • If you were using acombined pillin the previous month

Start using NuvaRing as late as the day after your current pill pause. If your pill package also contains inactive pills, start NuvaRing as late as the day after the last inactive pill. If you are unsure which pill is which, consult your doctor or pharmacist. Do not extend your pill pause beyond what is recommended.

If you have taken your current pill correctly and continuously and are sure you are not pregnant, you can stop taking the pill on any day of your cycle and start with NuvaRing immediately.

  • If you were using atransdermal patchin the previous month

Start using NuvaRing as late as the day after your patch-free pause. Do not extend your patch-free pause beyond what is recommended.

If you have used the patch correctly and continuously and are sure you are not pregnant, you can stop using the patch on any day and start with NuvaRing immediately.

  • If you were using aprogestin-only pillin the previous month

You can stop taking your progestin-only pill on any day and start NuvaRing the next day at the same time. However, make sure to use an additional contraceptive method (such as a male condom) during the first 7 days of using the ring.

  • If you were using aninjectable, an implant, or an Intrauterine System (IUS) with hormonal load (progestin)in the previous month

Start using NuvaRing at the time you should receive your next injection or the day your implant or IUS is removed. However, make sure to use an additional contraceptive method (such as a male condom) during the first 7 days of using the ring.

  • After childbirth

If you have just given birth, your doctor may advise you to wait until your first normal menstrual period before starting with NuvaRing. Sometimes, it is possible to start earlier; your doctor will advise you on how to do it. If you are breastfeeding and want to use NuvaRing, consult your doctor first.

  • After an abortion

Consult your doctor.

3.4 What to do if...

Your ring is expelled accidentally from the vagina

NuvaRing can be expelled accidentally from the vagina, for example, if it was not inserted correctly, when removing a tampon, during sexual intercourse, if you have constipation, or if you have uterine prolapse (uterine descent). Therefore, you should check regularly if the ring is in your vagina (for example, before and after sexual intercourse).

Your ring has been out of the vagina temporarily

NuvaRing may still protect you from pregnancy, but this will depend on how long it has been out of your vagina.

If the ring has been out of the vagina for:

  • less than 3 hours, it will still protect you from pregnancy. Wash the ring with cold or lukewarm water (do not use hot water) and put the ring back in the vagina as soon as possible but only if the ring has been out of the vagina for less than 3 hours.
  • more than 3 hours in the 1st or 2nd week, it may not protect you from pregnancy. Wash the ring with cold or lukewarm water (do not use hot water) and put the ring back in the vagina as soon as you remember. Leave it in the vagina for at least 7 consecutive days. Use a male condom if you have sexual intercourse during those 7 days. If you are in the first week and have had sexual intercourse in the previous 7 days, there is a possibility that you may be pregnant. In that case, consult your doctor.
  • more than 3 hours in the 3rd week, it may not protect you from pregnancy. Remove the ring and choose one of the two options below:
  1. Put a new ring in the vagina as soon as possible.

When you put on a new ring, you will start a new 3-week cycle of use. You may not experience your period. However, you may experience spotting (bloody discharge) or irregular bleeding during that cycle.

  1. Do not put on a new ring. Leave the spotting and put on a new ring no later than 7 days from the time the previous ring was removed or expelled.

Choose this option only if you have used NuvaRing consecutively for the previous 7 days.

  • an unknown period of time, it may not protect you from pregnancy. Perform a pregnancy test and consult your doctor before putting on a new ring.

Your ring has opened

In rare cases, the NuvaRing ring may open. Vaginal injury associated with ring rupture has been reported. If you notice that NuvaRing has opened, remove the ring and put on a new one as soon as possible. Take additional contraceptive precautions (such as a male condom) for the next 7 days. If you had sexual intercourse before noticing that the ring had opened, consult your doctor.

You have put on more than one ring

No serious injuries have been reported due to NuvaRing overdose. If you accidentally put on more than one ring, you may feel unwell (nausea), vomit, or experience vaginal bleeding. Remove the extra ring and contact your doctor if these symptoms do not subside. You can also call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount used.

If you forget to put on a new ring after the pause without a ring

Yourpause without a ringhas lastedmore than 7 days. Put a new ring in the vagina as soon as you remember. Take additional contraceptive precautions (such as a male condom) if you have sexual intercourse during the next 7 days.If you have had sexual intercourse during this pause without a ring, there is a possibility that you may be pregnant. In that case, inform your doctor immediately. The longer the pause without a ring, the higher the risk of pregnancy.

If you have forgotten to remove the ring

  • If the ring has been in the vagina for 3-4 weeks, it will still protect you from pregnancy. Leave the pause without a ring and put on a new ring.
  • If the ring has been in the vagina for more than 4 weeks, there is a possibility that you may be pregnant. Contact your doctor before starting with a new ring.

If you do not experience your period or menstrual bleeding

  • You have used NuvaRing as instructed.

If you do not experience your period, but have used NuvaRing as instructed and have not taken any other medications, it is highly unlikely that you are pregnant. Continue using NuvaRing as usual. However, if you have two consecutive missed periods, you may be pregnant, so inform your doctor immediately. Do not put on the next NuvaRing until your doctor has confirmed that you are not pregnant.

  • You have deviated from the recommended NuvaRing usage.

If you do not experience your menstrual bleeding during the pause without a ring and have deviated from the recommended regimen, there is a possibility that you may be pregnant, so contact your doctor before putting on a new ring.

If you experience unexpected vaginal bleeding

During the use of NuvaRing, some women may experience unexpected vaginal bleeding between their menstrual periods. You may need sanitary protection. However, continue using the ring as usual, do not remove it. If the bleeding continues, becomes heavier, or starts again, consult your doctor.

If you want to change the day when your period or menstrual bleeding starts

If you use NuvaRing as instructed, your menstrual period (withdrawal bleeding) will start during the pause without a ring. If you want to change the day when your period starts, you must shorten (never extend!) the pause without a ring.

For example, if your period usually starts on a Friday, you can change it to a Tuesday, i.e., 3 days earlier from the next month. Simply put on the next ring 3 days earlier than usual.

If the pause is made very short (e.g., 3 days or less), you may not experience your usual menstrual bleeding. You may experience spotting (bloody discharge) or irregular bleeding during the use of the next ring.

If you are unsure how to do it, consult your doctor.

If you want to delay your period or menstrual bleeding

Although this is not the recommended regimen, you can delay your menstrual bleeding by putting on a new ring immediately after removing the current ring, without leaving the pause between rings. You can leave the new ring in for a maximum of 3 weeks. During the use of the new ring, you may experience spotting (bloody discharge) or irregular bleeding. When you want your period to start, simply remove the ring. Leave the usual pause without a ring and put on a new ring.

You can consult your doctor before deciding to delay your menstrual bleeding.

3.5 If you want to stop using NuvaRing

You can stop using NuvaRing at any time you want. If you do not want to become pregnant, consult your doctor about other contraceptive methods.

If you stop using NuvaRing because you want to become pregnant, it is recommended to wait until you have had your first natural menstrual period before trying to conceive. This will help you calculate the due date.

4. Possible Adverse Effects

Like all medications, NuvaRing may cause side effects, although not all women will experience them. If you experience any side effect, especially if it is severe and persistent, or if you have any health changes that you think may be related to NuvaRing, consult your doctor.

All women taking combined hormonal contraceptives are at a higher risk of developing blood clots in the veins (venous thromboembolism (VTE)) or blood clots in the arteries (arterial thromboembolism (ATE)). For more detailed information on the different risks of taking combined hormonal contraceptives, see section 2 “What you need to know before starting to use NuvaRing”.

If you are allergic to any of the components of NuvaRing (hypersensitivity), you may experience the following symptoms (frequency not known): angioedema and/or anaphylaxis [swelling of the face, lips, tongue, and/or throat and/or difficulty swallowing] or urticaria, possibly with difficulty breathing. If this occurs, remove NuvaRing and contact your doctor immediately (see also section 2.2 “Warnings and precautions”).

Users of NuvaRing have reported the following side effects:

Frequent:may affect up to 1 in 10 women.

  • abdominal pain, discomfort (nausea)
  • vaginal yeast infection (similar to oral candidiasis), vaginal discomfort due to the ring, genital itching, vaginal discharge
  • headache or migraine, depressive mood, decreased libido
  • breast pain, pelvic pain, painful menstruation
  • acne
  • weight gain
  • expulsion of the ring

Infrequent:may affect up to 1 in 100 women.

  • vision changes, dizziness
  • swollen abdomen, vomiting, diarrhea, or constipation
  • feeling tired, uncomfortable, or irritable, mood changes, changes in mood
  • fluid retention in the body (edema)
  • urinary tract infection or bladder infection
  • difficulty, pain, or urgency while urinating; frequent need to urinate
  • sexual problems such as pain, bleeding, or the partner noticing the ring
  • increased blood pressure
  • increased appetite
  • back pain, muscle cramps, leg or arm pain
  • reduced skin sensitivity
  • tension or pain in the breasts or increased size; fibrocystic breast disease (cysts in the breasts that may become swollen or painful)
  • inflammation of the cervix, polyps that grow on the cervix, displacement of tissue from the inside of the cervix to the outside (ectropion)
  • changes in menstrual period (more intense, longer, irregular, or absent), pelvic discomfort, premenstrual syndrome, uterine cramps
  • vaginal infection (by fungi or bacteria), burning, odor, pain, discomfort, or dryness of the vagina or vulva
  • hair loss, eczema, itching, rash, or hot flashes
  • urticaria

Rare:may affect up to 1 in 1,000 women.

  • harmful blood clots in a vein or artery, for example:
  • in a leg or foot (i.e., DVT)
  • in a lung (i.e., PE)
  • heart attack
  • stroke
  • transient ischemic attack (TIA) or temporary symptoms similar to a stroke
  • blood clots in the liver, stomach/intestine, kidneys, or eye

The risk of having a blood clot may be higher if you have any other condition that increases this risk (see section 2 for more information on conditions that increase the risk of blood clots and symptoms of a blood clot).

  • breast secretion

Frequency not known:(cannot be estimated from available data).

  • melasma (yellow-brown patches on the skin, particularly on the face)
  • discomfort in the penis of the partner (irritation, rash, itching)
  • inability to remove the ring without medical assistance (e.g., due to its adherence to the vaginal wall)
  • vaginal injury associated with ring rupture

Cases of breast cancer and liver tumors have been reported in women using combined hormonal contraceptives. For more information, see section 2.2 “Warnings and precautions, Cancer”.

In very rare cases, the NuvaRing ring may open. For more information, see section 3.4 “What to do if… The ring opens.”

Reporting of side effects:

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of NuvaRing and the NuvaRing Applicator

Keep this medication out of the sight and reach of children.

If you discover that a child has been exposed to the hormones of NuvaRing, ask your doctor for advice.

Store below 86°F. Store in the original packaging to protect it from light and moisture.

Do not use NuvaRing if it was dispensed more than 4 months ago. The dispensing date is shown on the box and on each ring package.

Do not use NuvaRing after the expiration date that appears on the box and on each ring package.

Do not use NuvaRing if you observe changes in the color of the ring or any visible sign of deterioration.

Dispose of the used ring with household waste, preferably in its package with a closure.Dispose of the used applicatorwith regular household waste. NeitherNuvaRingnor the applicatorshould be thrown into the toilet.

Like other medications, do not throw away unused or expired rings through the drains or in the trash.

Medications should not be thrown away through the drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. In this way, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of NuvaRing

  • The active principles are etonogestrel (11.7 mg) and ethinylestradiol (2.7 mg).
  • The other components are: a copolymer of vinyl acetate and ethylene (28% and 9% vinyl acetate) (a type of plastic that does not dissolve in the body) and magnesium stearate.

Etonogestrel and ethinylestradiol are released from the ring at a ratio of 0.120 mg/day and 0.015 mg/day respectively, over three weeks.

Appearance of NuvaRing andof the NuvaRing Applicator andcontents of the packaging

NuvaRing is a flexible, transparent, and almost colorless ring, measuring 54 mm in width.

Each ring is packaged in a laminated aluminum foil pouch that can be resealed.

The applicator is a non-sterile plastic device, designed for single use (i.e., disposable). Each applicator is individually packaged. The applicator has the CE mark engraved on it.

The ring or rings and applicator or applicators are presented in a cardboard box along with this leaflet. Each box contains 1 or 3 rings and the corresponding applicator or applicators.

Only some packaging sizes may be marketed.

Marketing Authorization Holder and Responsible Manufacturer

Marketing Authorization Holder:

Organon Salud, S.L.

Paseo de la Castellana, 77

28046 Madrid

Spain

Phone: 915911279

Responsible Manufacturer:

N.V. Organon

Kloosterstraat 6,

5349 ABOss

Netherlands

This medicinal product is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following name:

NuvaRing

0.120 mg/0.015 mg every 24 hours, vaginal delivery system

Germany, Austria, Belgium, Czech Republic, Denmark, Spain, Slovakia, Slovenia, Estonia, Finland, France, Greece, Hungary, Ireland, Iceland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway,Netherlands,Poland, Portugal, United Kingdom(Northern Ireland), Romania, Sweden.

Date of the last review of this leaflet:09/2022.

Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)

Country of registration
Prescription required
Yes
Manufacturer
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.

Talk to a doctor online

Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.

5.01 review
Doctor

Анна Морет

Дерматологія18 years of experience

Анна Морет — лікарка-дерматолог і дерматовенеролог із міжнародною сертифікацією. Спеціалізується на дерматології дорослих і дітей, венерології, естетичному догляді за шкірою та загальній медицині. Проводить онлайн-консультації, базуючись на доказовій медицині та індивідуальних потребах кожного пацієнта.

Сфера допомоги охоплює: • захворювання шкіри: екзема, акне, розацеа, дерматити, псоріаз • проблеми з волоссям і шкірою голови: випадіння волосся, лупа, себорейний дерматит • дитяча дерматологія — від новонароджених до підлітків • венерологія та інфекції, що передаються статевим шляхом (ІПСШ) • естетичні запити: вікові зміни шкіри, неінвазивні косметологічні процедури • алергічні реакції та підвищена чутливість шкіри • перевірка родимок, оцінка новоутворень, скринінг раку шкіри • поради щодо догляду за шкірою та підбір індивідуальної космецевтики

Поєднуючи дерматологію із загальноклінічним досвідом, Анна Морет надає всебічну допомогу, що охоплює як стан шкіри, так і супутні захворювання. Має сертифікацію Канадської ради естетичної медицини, що підтверджує міжнародний підхід до естетичної дерматології.

Book a video appointment
5.01 review
Doctor

Аліна Цуркан

Сімейна медицина12 years of experience

Аліна Цуркан — ліцензована лікарка сімейної медицини в Португалії. Проводить онлайн-консультації для дорослих і дітей, допомагаючи пацієнтам у вирішенні широкого спектра щоденних медичних запитів з професійним підходом і увагою до деталей.

Звернутися можна з такими станами: • респіраторні інфекції: застуда, грип, бронхіт, пневмонія • Захворювання очей: кон’юнктивіт (інфекційний і алергічний) • ЛОР-захворювання: синусит, отит, тонзиліт • проблеми з травленням: гастрит, кислотний рефлюкс, синдром подразненого кишківника (СПК) • інфекції сечових шляхів та інші поширені інфекції • хронічні захворювання: артеріальна гіпертензія, діабет, порушення функції щитоподібної залози • головний біль і мігрень

Окрім лікування симптомів, Аліна Цуркан приділяє особливу увагу профілактиці та ранньому виявленню захворювань. Проводить планові огляди, надає медичні рекомендації, здійснює повторні консультації та виписує рецепти — з урахуванням індивідуальних потреб кожного пацієнта.

Її підхід — комплексний, уважний і адаптований до кожного етапу життя пацієнта: від гострих станів до довготривалого контролю здоров’я.

Book a video appointment
5.09 reviews
Doctor

Андрій Попов

Терапія6 years of experience

Андрій Попов — ліцензований в Іспанії терапевт і фахівець із лікування болю. Проводить онлайн-консультації для дорослих, допомагаючи впоратися з хронічним і гострим болем, а також із широким спектром загальних медичних запитів.

Спеціалізується на діагностиці та лікуванні болю, що триває понад 3 місяці або суттєво знижує якість життя. Працює з такими станами, як: • хронічний біль будь-якого походження • мігрень і повторювані головні болі • біль у шиї, спині, попереку та суглобах • посттравматичний біль після травм, розтягнень або операцій • невропатичний біль, фіброміалгія, невралгії

Окрім знеболення, Андрій Попов допомагає пацієнтам у веденні загальних медичних станів, зокрема: • респіраторні інфекції (застуда, бронхіт, пневмонія) • артеріальна гіпертензія, порушення обміну речовин, цукровий діабет • профілактичні огляди та контроль загального стану здоров’я

Онлайн-консультація триває до 30 хвилин і включає детальний аналіз симптомів, рекомендації щодо обстежень, формування індивідуального плану лікування та подальший супровід за потреби.

Андрій Попов дотримується принципів доказової медицини, поєднуючи клінічний досвід із уважним і персоналізованим підходом до кожного пацієнта.

Book a video appointment
5.01 review
Doctor

Євген Яковенко

Загальна хірургія11 years of experience

Євген Яковенко — ліцензований лікар-хірург і терапевт в Іспанії. Спеціалізується на загальній і дитячій хірургії, внутрішній медицині та лікуванні болю. Проводить онлайн-консультації для дорослих і дітей, поєднуючи хірургічну практику з терапевтичним супроводом.

Сфера медичної допомоги охоплює: • діагностику та лікування гострого й хронічного болю • перед- і післяопераційний супровід, оцінку ризиків, контроль стану • хірургічні захворювання: грижі, жовчнокам’яна хвороба, апендицит • консультації з дитячої хірургії: вроджені стани, дрібні втручання • травми: переломи, ушкодження м’яких тканин, обробка ран • онкохірургія: консультації, планування, супровід після лікування • внутрішні захворювання: патології серцево-судинної та дихальної систем • ортопедичні стани, реабілітація після травм • інтерпретація результатів візуалізації для хірургічного планування

Євген Яковенко активно займається науковою діяльністю та міжнародною співпрацею. Член Асоціації хірургів Німеччини (BDC), співпрацює з Асоціацією сімейних лікарів Лас-Пальмаса та Німецьким консульством на Канарських островах. Регулярно бере участь у міжнародних медичних конференціях і публікує наукові статті.

Поєднуючи багатопрофільний досвід із доказовою медициною, він надає точну та індивідуалізовану допомогу для пацієнтів із різними медичними запитами.

Book a video appointment
See all doctors

Stay informed and save on care

Get health tips, platform updates, and exclusive promos for subscribers.

Follow us on social media
ServicesDoctorsHelp
Search